Log in with your email address username.


[Editorial] Brexit’s effect on access to new medicines

The latest warning of the negative outcomes of Brexit on the UK’s life sciences sector (medicines, therapies, and biotechnologies) came from a report published last week by the UK think tank, Public Policy Projects. The report highlights the challenges from a regulatory, funding, and patient access to new medicines perspective under different Brexit scenarios.